NEW YORK (GenomeWeb) – CombiMatrix reported after the close of the market Thursday that its first quarter revenues climbed 27 percent driven by an uptick in its reproductive health test sales.

The Irvine, California-based molecular diagnostics firm reported total revenues of $3.8 million, up from $3 million in the first quarter of 2016. It noted that its reproductive health test sales were up 32 percent year over year to $2.9 million, while volume for such tests were up 15 percent to 1,642 in the quarter. Its total test volume increased 11 percent year over year to 2,938.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.